TELA Bio (TELA) Net Margin (2018 - 2026)

TELA Bio's Net Margin history runs 9 years deep, the most recent figure standing at 64.39% for Q1 2026.

• In Q1 2026, Net Margin fell 357.0% year-over-year to 64.39%; the TTM figure through Mar 2026 stood at 49.81% (down 4280.0% YoY), while the FY2025 annual figure was 48.89%, down 4998.0% from the prior year.
• Net Margin was 64.39% for Q1 2026 at TELA Bio, down from 45.3% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 165.72% in Q4 2024 to a low of 130.66% in Q1 2022.
• Historically, Net Margin has averaged 60.49% across 5 years, with a median of 76.5% in 2023.
• The sharpest annual moves came in 2024 and 2025: Net Margin soared 24587 bps in 2024, then tumbled 21102 bps in 2025.
• A 5-year view of Net Margin shows it stood at 91.32% in 2022, then climbed by 12 bps to 80.14% in 2023, then soared by 307 bps to 165.72% in 2024, then plunged by 127 bps to 45.3% in 2025, then slumped by 42 bps to 64.39% in 2026.
• The last three Net Margin figures came in at 64.39% (Q1 2026), 45.3% (Q4 2025), and 41.58% (Q3 2025), per Business Quant data.